West Midlands HealthTech/MedTech ‘6D’ Innovation Accelerator

医疗保健技术和医疗技术部门目前对英国来说每年价值170亿GB，随着人口老龄化和大流行后健康状况不佳，预计到2027年将增长到每年210亿GB。然而，这些行业相对较高的监管水平，可能会使新公司将他们的技术带入英国市场的速度和成本都很慢，这一点阻碍了与其他全球竞争对手相比的增长。西米德兰兹郡的6D创新加速器(6D-IA)将联合整个地区的关键参与者(大学、医院、行业和政府资助的制造业创新弹射器)，通过创造一个支持性环境来加速新技术商业化，以解决这些问题。合作伙伴将开展一系列集中协调的活动，帮助公司在医学翻译过程中找到“夹点”。我们的‘6D’包括公司需求的诊断；NHS的定义或需要应对的公司挑战；原型产品或服务的开发和改进；在现实世界NHS环境中部署创新；跨部门合作的多样化；以及我们干预措施的经济效益展示。它还将确保当地患者首先受益于旨在减少重大地区医疗不平等的新医疗技术。6D-IA还将为开发和部署新的医疗技术提供全国重点，发展以新的Precision Healthcare Technology Accelerator为中心的充满活力和自我维持的活动集群，利用最近的重大私人投资以及重要的地区资产来吸引和支持医疗创新者。6D-IA将通过加强大伯明翰地区具有强大的地区和国家联系的活动集群，将西米德兰兹郡置于英国医疗创新的前沿。它将促进该区域内的经济活动，到2026/27年吸引高达8000万至1亿GB的额外私人投资。它还将促进医疗保健提供的转变，方法是将重点放在开发新的数字化创新上，提供强有力的二级保健原则证明，并在社区和初级保健方面开展相关试点工作。

The Healthcare Technology and Medical Technology sectors are currently worth £17billion per annum to the UK, and with the ageing population and poor health following the pandemic, are projected to grow to £21billion per annum by 2027\. However, the relatively high levels of regulation in these sectors, can make it slow and expensive for new companies to bring their technologies to the UK market, something that has hindered growth comparative to other global competitors.The West Midlands '6D' Innovation Accelerator (6D-IA) will unite key players across the region (universities, hospitals, industry and government-funded 'Catapults' for manufacturing innovation) to address these problems by creating a supportive environment to accelerate new technologies towards commercialisation. The partners will run a centrally coordinated series of activities that will help companies to navigate "pinch-points" in the process of medical translation. Our '6Ds' include diagnosis of company needs; definition of NHS or corporate challenges to respond to; development and refinement of prototype products or services; deployment of innovation in real-world NHS settings; diversification of cross-sectoral collaborations; and demonstration of economic benefit for our interventions.Together, this will create a cluster of commercial activity in this sector, helping to drive regional economic growth and enhance resilience. It will also ensure that local patients will benefit first from new medical technologies targeted at reducing significant regional healthcare inequalities. The 6D-IA will also provide a national focus for the development and deployment of new healthcare technologies, growing a vibrant and self-sustaining cluster of activity centred in the new Precision Healthcare Technology Accelerator, leveraging major recent private investment alongside significant regional assets to attract and support medical innovators.The 6D-IA will place the West Midlands at the forefront of UK medical innovation by supercharging a cluster of activity in the Greater Birmingham area with strong regional and national links. It will boost economic activity within the region, attracting up to £80-100million in additional private investment by 2026/27\. It will also facilitate the transformation of the delivery of healthcare by creating a strong focus on the development of new digitally-enabled innovations, providing strong secondary care proof-of-principle with associated pilot work in community and primary care.